Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Feb 28;12(2):184-186.
doi: 10.21037/tlcr-23-34. Epub 2023 Feb 23.

Surgical series in mesothelioma: navigating between biases

Jo Raskin  1 , Paul E Van Schil  2 , Jan P Van Meerbeeck  1
Affiliations
Editorial

Surgical series in mesothelioma: navigating between biases

Jo Raskin et al. Transl Lung Cancer Res. .
No abstract available

Keywords: Mesothelioma; bias; surgery.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-23-34/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Klotz LV, Hoffmann H, Shah R, et al. Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach. Transl Lung Cancer Res 2022;11:2230-42. 10.21037/tlcr-22-199 - DOI - PMC - PubMed
    1. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-63; discussion 63-5. 10.1016/S0022-5223(99)70469-1 - DOI - PubMed
    1. Hillerdal G, Sorensen JB, Sundström S, et al. Treatment of malignant pleural mesothelioma with carboplatin, liposomized doxorubicin, and gemcitabine: a phase II study. J Thorac Oncol 2008;3:1325-31. 10.1097/JTO.0b013e31818b174d - DOI - PubMed
    1. Treasure T, Lang-Lazdunski L, Waller D, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011;12:763-72. 10.1016/S1470-2045(11)70149-8 - DOI - PMC - PubMed
    1. Krug LM, Pass HI, Rusch VW, et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009;27:3007-13. 10.1200/JCO.2008.20.3943 - DOI - PMC - PubMed